questionsmedicales.fr
Composés hétérocycliques
Composés hétérocycliques à cycles fusionnés
Composés hétérobicycliques
Benzimidazoles
(Pyridin-2-ylméthyl)sulfinyl-1H-benzimidazoles
Oméprazole
Oméprazole : Questions médicales fréquentes
Diagnostic
5
Reflux gastro-œsophagien
Endoscopie
pH-métrie
Oméprazole
Évaluation clinique
Endoscopie
Brûlures d'estomac
Douleurs thoraciques
Oméprazole
Ulcère
Reflux gastro-œsophagien
Symptômes
Saignements
Vomissements
Perte de poids
Symptômes
5
Effets secondaires
Maux de tête
Nausées
Oméprazole
Douleurs abdominales
Effets indésirables
Surdose
Vertiges
Eruptions cutanées
Digestion
Acidité gastrique
Oméprazole
Ballonnements
Effets secondaires
Oméprazole
Prévention
5
Prévention
Brûlures d'estomac
Mode de vie
Alimentation
Prévention
Irritants gastriques
Tabagisme
Reflux
Ulcères gastriques
Stress
Acide gastrique
Symptômes
Exercice
Prévention
Digestion
Traitements
5
Oméprazole
Administration
Jeûne
Durée du traitement
Ulcères
Oméprazole
Brûlures d'estomac
Efficacité
Oméprazole
Interactions médicamenteuses
Oméprazole
Consultation médicale
Alimentation
Symptômes
Oméprazole
Complications
5
Reflux gastro-œsophagien
Complications
Cancer de l'œsophage
Carences nutritionnelles
Oméprazole
Vitamine B12
Surdose
Oméprazole
Troubles neurologiques
Flore intestinale
Infections digestives
Oméprazole
Résistance
Oméprazole
Ajustement du traitement
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Oméprazole : Questions médicales les plus fréquentes",
"headline": "Oméprazole : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Oméprazole : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-21",
"dateModified": "2026-04-12",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Oméprazole"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "(Pyridin-2-ylméthyl)sulfinyl-1H-benzimidazoles",
"url": "https://questionsmedicales.fr/mesh/D053799",
"about": {
"@type": "MedicalCondition",
"name": "(Pyridin-2-ylméthyl)sulfinyl-1H-benzimidazoles",
"code": {
"@type": "MedicalCode",
"code": "D053799",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.103.034"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Ésoméprazole",
"alternateName": "Esomeprazole",
"url": "https://questionsmedicales.fr/mesh/D064098",
"about": {
"@type": "MedicalCondition",
"name": "Ésoméprazole",
"code": {
"@type": "MedicalCode",
"code": "D064098",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.103.034.500.500"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Oméprazole",
"alternateName": "Omeprazole",
"code": {
"@type": "MedicalCode",
"code": "D009853",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Saeed Abdi",
"url": "https://questionsmedicales.fr/author/Saeed%20Abdi",
"affiliation": {
"@type": "Organization",
"name": "Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran."
}
},
{
"@type": "Person",
"name": "Mohammad Abbasinazari",
"url": "https://questionsmedicales.fr/author/Mohammad%20Abbasinazari",
"affiliation": {
"@type": "Organization",
"name": "Department of Clinical Pharmacy, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran."
}
},
{
"@type": "Person",
"name": "Kenza Abouir",
"url": "https://questionsmedicales.fr/author/Kenza%20Abouir",
"affiliation": {
"@type": "Organization",
"name": "Division of Clinical Pharmacology and Toxicology, Geneva University Hospitals, Geneva, Switzerland."
}
},
{
"@type": "Person",
"name": "Emmanuel Varesio",
"url": "https://questionsmedicales.fr/author/Emmanuel%20Varesio",
"affiliation": {
"@type": "Organization",
"name": "School of Pharmaceutical Sciences; Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, Geneva, Switzerland."
}
},
{
"@type": "Person",
"name": "Caroline Samer",
"url": "https://questionsmedicales.fr/author/Caroline%20Samer",
"affiliation": {
"@type": "Organization",
"name": "Division of Clinical Pharmacology and Toxicology, Geneva University Hospitals, Geneva, Switzerland."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Unexpected cause of Kounis syndrome: hypersensitivity reaction to omeprazole.",
"datePublished": "2023-10-24",
"url": "https://questionsmedicales.fr/article/37879707",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1136/bcr-2023-254799"
}
},
{
"@type": "ScholarlyArticle",
"name": "Safety analysis of co-administering tacrolimus and omeprazole in renal transplant recipients - A review.",
"datePublished": "2023-08-22",
"url": "https://questionsmedicales.fr/article/37619481",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.biopha.2023.115149"
}
},
{
"@type": "ScholarlyArticle",
"name": "Different effects of chronic omeprazole use on osteoporotic fractures rate in the elderly.",
"datePublished": "2023-08-04",
"url": "https://questionsmedicales.fr/article/37463830",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/bcp.15847"
}
},
{
"@type": "ScholarlyArticle",
"name": "The Effects of Omeprazole on the Neuron-like Spiking of the Electrical Potential of Proteinoid Microspheres.",
"datePublished": "2024-10-04",
"url": "https://questionsmedicales.fr/article/39407628",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/molecules29194700"
}
},
{
"@type": "ScholarlyArticle",
"name": "Omeprazole and risk of osteoarthritis: insights from a mendelian randomization study in the UK Biobank.",
"datePublished": "2024-05-27",
"url": "https://questionsmedicales.fr/article/38802944",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12967-024-05255-y"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Composés hétérocycliques",
"item": "https://questionsmedicales.fr/mesh/D006571"
},
{
"@type": "ListItem",
"position": 3,
"name": "Composés hétérocycliques à cycles fusionnés",
"item": "https://questionsmedicales.fr/mesh/D000072471"
},
{
"@type": "ListItem",
"position": 4,
"name": "Composés hétérobicycliques",
"item": "https://questionsmedicales.fr/mesh/D006574"
},
{
"@type": "ListItem",
"position": 5,
"name": "Benzimidazoles",
"item": "https://questionsmedicales.fr/mesh/D001562"
},
{
"@type": "ListItem",
"position": 6,
"name": "(Pyridin-2-ylméthyl)sulfinyl-1H-benzimidazoles",
"item": "https://questionsmedicales.fr/mesh/D053799"
},
{
"@type": "ListItem",
"position": 7,
"name": "Oméprazole",
"item": "https://questionsmedicales.fr/mesh/D009853"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Oméprazole - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Oméprazole",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-05-09",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Oméprazole",
"description": "Comment diagnostiquer un reflux gastro-œsophagien ?\nQuels tests pour évaluer l'efficacité de l'Oméprazole ?\nQuels symptômes indiquent un besoin d'Oméprazole ?\nComment différencier ulcère et reflux ?\nQuels signes nécessitent une consultation rapide ?",
"url": "https://questionsmedicales.fr/mesh/D009853#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Oméprazole",
"description": "Quels sont les effets secondaires courants de l'Oméprazole ?\nL'Oméprazole peut-il causer des douleurs abdominales ?\nQuels symptômes indiquent une surdose d'Oméprazole ?\nComment l'Oméprazole affecte-t-il la digestion ?\nPeut-on ressentir des ballonnements avec l'Oméprazole ?",
"url": "https://questionsmedicales.fr/mesh/D009853#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Oméprazole",
"description": "Comment prévenir les brûlures d'estomac ?\nL'alimentation joue-t-elle un rôle dans la prévention ?\nLe tabagisme influence-t-il les symptômes ?\nComment le stress affecte-t-il l'estomac ?\nDes exercices peuvent-ils aider à prévenir les symptômes ?",
"url": "https://questionsmedicales.fr/mesh/D009853#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Oméprazole",
"description": "Comment prendre l'Oméprazole correctement ?\nCombien de temps dure un traitement avec l'Oméprazole ?\nL'Oméprazole est-il efficace contre les brûlures d'estomac ?\nPeut-on combiner l'Oméprazole avec d'autres médicaments ?\nQuels aliments éviter pendant le traitement ?",
"url": "https://questionsmedicales.fr/mesh/D009853#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Oméprazole",
"description": "Quelles sont les complications possibles d'un reflux non traité ?\nL'Oméprazole peut-il causer des carences nutritionnelles ?\nQuels sont les risques d'une surdose d'Oméprazole ?\nComment l'Oméprazole affecte-t-il la flore intestinale ?\nPeut-on développer une résistance à l'Oméprazole ?",
"url": "https://questionsmedicales.fr/mesh/D009853#section-complications"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer un reflux gastro-œsophagien ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic se fait par endoscopie, pH-métrie et évaluation des symptômes."
}
},
{
"@type": "Question",
"name": "Quels tests pour évaluer l'efficacité de l'Oméprazole ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "On utilise des tests de pH, des endoscopies et l'évaluation des symptômes cliniques."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un besoin d'Oméprazole ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les brûlures d'estomac fréquentes et les douleurs thoraciques peuvent indiquer un besoin."
}
},
{
"@type": "Question",
"name": "Comment différencier ulcère et reflux ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'ulcère présente des douleurs plus localisées, souvent soulagées par la nourriture."
}
},
{
"@type": "Question",
"name": "Quels signes nécessitent une consultation rapide ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des saignements, des vomissements ou une perte de poids inexpliquée doivent alerter."
}
},
{
"@type": "Question",
"name": "Quels sont les effets secondaires courants de l'Oméprazole ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires incluent des maux de tête, des nausées et des diarrhées."
}
},
{
"@type": "Question",
"name": "L'Oméprazole peut-il causer des douleurs abdominales ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des douleurs abdominales peuvent survenir comme effet secondaire de l'Oméprazole."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une surdose d'Oméprazole ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme des vertiges, des éruptions cutanées ou des douleurs thoraciques peuvent survenir."
}
},
{
"@type": "Question",
"name": "Comment l'Oméprazole affecte-t-il la digestion ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'Oméprazole réduit l'acidité gastrique, ce qui peut ralentir la digestion des aliments."
}
},
{
"@type": "Question",
"name": "Peut-on ressentir des ballonnements avec l'Oméprazole ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains patients rapportent des ballonnements comme effet secondaire de ce médicament."
}
},
{
"@type": "Question",
"name": "Comment prévenir les brûlures d'estomac ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter les repas copieux, réduire le stress et ne pas s'allonger après avoir mangé."
}
},
{
"@type": "Question",
"name": "L'alimentation joue-t-elle un rôle dans la prévention ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation équilibrée et éviter les irritants gastriques peuvent aider."
}
},
{
"@type": "Question",
"name": "Le tabagisme influence-t-il les symptômes ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme peut aggraver les symptômes de reflux et d'ulcères gastriques."
}
},
{
"@type": "Question",
"name": "Comment le stress affecte-t-il l'estomac ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress peut augmenter la production d'acide gastrique, aggravant les symptômes."
}
},
{
"@type": "Question",
"name": "Des exercices peuvent-ils aider à prévenir les symptômes ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des exercices modérés peuvent améliorer la digestion et réduire les symptômes."
}
},
{
"@type": "Question",
"name": "Comment prendre l'Oméprazole correctement ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'Oméprazole doit être pris à jeun, généralement 30 minutes avant un repas."
}
},
{
"@type": "Question",
"name": "Combien de temps dure un traitement avec l'Oméprazole ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "La durée du traitement varie, mais elle est souvent de 4 à 8 semaines pour les ulcères."
}
},
{
"@type": "Question",
"name": "L'Oméprazole est-il efficace contre les brûlures d'estomac ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'Oméprazole est efficace pour réduire les brûlures d'estomac en diminuant l'acidité."
}
},
{
"@type": "Question",
"name": "Peut-on combiner l'Oméprazole avec d'autres médicaments ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines combinaisons sont possibles, mais il est essentiel de consulter un médecin."
}
},
{
"@type": "Question",
"name": "Quels aliments éviter pendant le traitement ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est conseillé d'éviter les aliments épicés, acides et gras qui aggravent les symptômes."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles d'un reflux non traité ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent l'œsophagite, les ulcères et le risque de cancer de l'œsophage."
}
},
{
"@type": "Question",
"name": "L'Oméprazole peut-il causer des carences nutritionnelles ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une utilisation prolongée peut entraîner des carences en vitamine B12 et en magnésium."
}
},
{
"@type": "Question",
"name": "Quels sont les risques d'une surdose d'Oméprazole ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une surdose peut provoquer des symptômes graves comme des troubles neurologiques et cardiaques."
}
},
{
"@type": "Question",
"name": "Comment l'Oméprazole affecte-t-il la flore intestinale ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'Oméprazole peut perturber la flore intestinale, augmentant le risque d'infections digestives."
}
},
{
"@type": "Question",
"name": "Peut-on développer une résistance à l'Oméprazole ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains patients peuvent développer une résistance, nécessitant un ajustement du traitement."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 12/04/2026
Contenu vérifié selon les dernières recommandations médicales
2 publications dans cette catégorie
Affiliations :
Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Publications dans "Oméprazole" :
2 publications dans cette catégorie
Affiliations :
Department of Clinical Pharmacy, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Publications dans "Oméprazole" :
2 publications dans cette catégorie
Affiliations :
Division of Clinical Pharmacology and Toxicology, Geneva University Hospitals, Geneva, Switzerland.
School of Pharmaceutical Sciences; Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, Geneva, Switzerland.
Publications dans "Oméprazole" :
2 publications dans cette catégorie
Affiliations :
School of Pharmaceutical Sciences; Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, Geneva, Switzerland.
Publications dans "Oméprazole" :
2 publications dans cette catégorie
Affiliations :
Division of Clinical Pharmacology and Toxicology, Geneva University Hospitals, Geneva, Switzerland.
School of Pharmaceutical Sciences; Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, Geneva, Switzerland.
Faculty of Medicine, University of Geneva, Geneva, Switzerland.
Publications dans "Oméprazole" :
2 publications dans cette catégorie
Affiliations :
Division of Clinical Pharmacology and Toxicology, Geneva University Hospitals, Geneva, Switzerland.
School of Pharmaceutical Sciences; Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, Geneva, Switzerland.
Faculty of Medicine, University of Geneva, Geneva, Switzerland.
Publications dans "Oméprazole" :
2 publications dans cette catégorie
Affiliations :
Traditional Medicine and Materia Medica Research Center and Department of Traditional Pharmacy, School of Traditional Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Publications dans "Oméprazole" :
2 publications dans cette catégorie
Affiliations :
Proteomics Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Publications dans "Oméprazole" :
2 publications dans cette catégorie
Affiliations :
Traditional Medicine and Materia Medica Research Center and Department of Traditional Pharmacy, School of Traditional Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Publications dans "Oméprazole" :
2 publications dans cette catégorie
Affiliations :
Proteomics Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Publications dans "Oméprazole" :
2 publications dans cette catégorie
Affiliations :
Department of Clinical Pharmacology, Tergooi Hospital, Hilversum, The Netherlands.
Publications dans "Oméprazole" :
2 publications dans cette catégorie
Affiliations :
Department for Health Evidence, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
Publications dans "Oméprazole" :
2 publications dans cette catégorie
Affiliations :
Department of Clinical Pharmacology, St Antonius Hospital, Nieuwegein, The Netherlands.
Division of Pharmacology, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands.
Publications dans "Oméprazole" :
2 publications dans cette catégorie
Affiliations :
Department of Paediatrics, Tergooi Hospital, Hilversum, The Netherlands. fbplotz@tergooi.nl.
Department of Paediatrics, Emma Children's Hospital, Amsterdam UMC, Amsterdam, The Netherlands. fbplotz@tergooi.nl.
Publications dans "Oméprazole" :
2 publications dans cette catégorie
Affiliations :
Department of Pharmacology and Toxicology, Radboud Institute Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
Paediatric Intensive Care and Department of Paediatric Surgery, Erasmus MC Sophia, Rotterdam, The Netherlands.
Publications dans "Oméprazole" :
2 publications dans cette catégorie
Affiliations :
Division of Anatomy, Department of Biomedical Sciences, Faculty of Allied Health Sciences, Burapha University, Chonburi 20131, Thailand.
Publications dans "Oméprazole" :
2 publications dans cette catégorie
Affiliations :
Division of Physiology, Department of Biomedical Sciences, Faculty of Allied Health Sciences, Burapha University, Chonburi 20131, Thailand. narongritt@buu.ac.th.
Publications dans "Oméprazole" :
2 publications dans cette catégorie
Affiliations :
Postgraduate Program in Biotechnology (RENORBIO), Federal University of Piauí, Teresina, PI, Brazil.
Laboratory of Genetic Toxicity, Postgraduate Program in Pharmaceutical Sciences, Federal University of Piauí, Teresina, PI, Brazil.
Publications dans "Oméprazole" :
2 publications dans cette catégorie
Affiliations :
University Centre UNINTA, Sobral, CE, Brazil.
Publications dans "Oméprazole" :
2 publications dans cette catégorie
Affiliations :
Laboratory of Genetic Toxicity, Postgraduate Program in Pharmaceutical Sciences, Federal University of Piauí, Teresina, PI, Brazil.
University Centre UNINOVAFAPI, Teresina, PI, Brazil.
Publications dans "Oméprazole" :
Kounis syndrome is a rare type of acute coronary syndrome (ACS) that occurs as a result of an allergic or anaphylactic reaction. Kounis syndrome can be induced by various medications including antibio...
Tacrolimus is a calcineurin inhibitor used to prevent rejection in allogenic solid organ transplant recipients, which is metabolized in the liver with cytochrome P450 isoforms 3A4 and 3A5 (CYP3A4, CYP...
To investigate the potential association of chronic use of omeprazole with the occurrence of osteoporotic fractures (OF) in community-dwelling elderly subjects....
The cohort consisted of community-dwelling residents aged >65 years registered with a large health maintenance organization in Israel between January 2002 and December 2016. Data were retrospectively ...
In total, 46 805 subjects were included (41% men), mean age 83.4±6.4 years, of whom 10 272 (21.9%) were chronic users of omeprazole. During 14 years of follow-up, OF were diagnosed in 414 (4.0%) omepr...
Chronic use of omeprazole was not associated with the occurrence of OF in elders....
This study examines a new approach to hybrid neuromorphic devices by studying the impact of omeprazole-proteinoid complexes on Izhikevich neuron models. We investigate the influence of these metabolic...
A former cohort study has raised concern regarding the unanticipated hazard of omeprazole in expediting osteoarthritis (OA) advancement. The precise nature of their causal evidence, however, remains u...
The study incorporated the ukb-a-106 and ukb-b-14,486 datasets. The investigation of causal effects employed methodologies such as MR-Egger, Weighted median, Inverse variance weighted (IVW) with multi...
The outcomes of the MR analysis indicated a causal relationship between omeprazole and OA, with omeprazole identified as a contributing risk factor for OA development (IVW model: OR = 1.2473, P < 0.01...
This study, employing MR, reveals that omeprazole, as an exposure factor, elevates the risk of OA. Considering the drug's efficacy and associated adverse events, clinical practitioners should exercise...
It is unclear whether the s (-) form of esomeprazole (EPZ) has an improved safety profile when compared with its racemic form omeprazole (OPZ). We assessed the potential complications of these optical...
Using two adverse event spontaneous reporting databases, Japanese Adverse Drug Event Report (JADER) and FDA Adverse Event Reporting System (FAERS), adverse event names for hemorrhage, venous/arterial ...
In combination with cilostazol, a hemorrhagic signal for OPZ in JADER and arterial emboli and thrombus signals for EPZ were detected in both databases. In combination with clopidogrel, OPZ showed arte...
This study has confirmed using big data, that EPZ, the optical isomer and racemic form of omeprazole, has the beneficial characteristics of being less sensitive to CYP, as was intended by its design....
Oral extended-release (ER) dosage forms have been used to sustain blood drug levels, reduce adverse events, and improve patient compliance. We investigated potential effects of comedication on pharmac...
Cytochrome P450 CYP102A1 is a prototypic biocatalyst that has great potential in chemical synthesis, drug discovery, and biotechnology. CYP102A1 variants engineered by directed evolution and/or ration...
The production of 3D printed pharmaceuticals has thrived in recent years, as it allows the generation of customised medications in small batches. This is particularly helpful for patients who need spe...
Clostridioides difficile infection (CDI) is associated with high recurrence rates that have substantial effects on patients' quality of life. To investigate the risk factors and potential mechanisms c...